Capricor Therapeutics, Inc. (CAPR)
6.61
-0.04
(-0.60%)
USD |
NASDAQ |
Oct 20, 16:00
6.60
-0.01
(-0.15%)
After-Hours: 07:17
Capricor Therapeutics Gross Profit (TTM) : -2.095M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.095M |
| March 31, 2026 | -2.019M |
| December 31, 2025 | -1.890M |
| September 30, 2025 | 9.368M |
| June 30, 2025 | 11.76M |
| March 31, 2025 | 15.86M |
| December 31, 2024 | 20.85M |
| September 30, 2024 | 21.87M |
| June 30, 2024 | 25.88M |
| March 31, 2024 | 25.93M |
| December 31, 2023 | 24.12M |
| September 30, 2023 | 13.12M |
| June 30, 2023 | 8.639M |
| March 31, 2023 | 4.858M |
| December 31, 2022 | 1.844M |
| September 30, 2022 | 0.9905M |
| June 30, 2022 | -0.506M |
| March 31, 2022 | -0.3939M |
| December 31, 2021 | -0.1434M |
| September 30, 2021 | -0.0647M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3672M |
| December 31, 2019 | 0.3672M |
| September 30, 2019 | 0.3672M |
| June 30, 2019 | 0.3672M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0256M |
| June 30, 2014 | -0.0257M |
| March 31, 2014 | -0.0259M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | 83.45M |
| SELLAS Life Sciences Group, Inc. | 0.00 |
| Sionna Therapeutics, Inc. | -0.561M |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Cytokinetics, Inc. | 46.98M |